Short answer: does Ozempic cause hair loss?
Hair loss is reported with GLP-1 medicines, but in clinical trials it affected a minority of people, and the prescribing labels link it to weight reduction. In the weight-management trials of Wegovy (semaglutide), 3% of adults reported hair loss compared with 1% on placebo (Wegovy prescribing information). For Zepbound (tirzepatide), the figure was 4% to 5% across the doses studied versus 1% on placebo (Zepbound prescribing information). Hair loss is not listed among the common adverse reactions in the Ozempic label, which covers type 2 diabetes treatment, although people taking it do report shedding (Drugs.com).
Most experts think the main driver is telogen effluvium, a temporary shedding pattern that can follow any significant physical stress, including losing a lot of weight quickly. Our telogen effluvium guide covers the condition in depth.
What the trials and labels report
| Medicine (ingredient) | Hair loss on medicine | Hair loss on placebo | Source |
|---|---|---|---|
| Wegovy (semaglutide), adults | 3% | 1% | Wegovy label |
| Wegovy (semaglutide), ages 12 and up | 4% | 0% | Wegovy label |
| Zepbound (tirzepatide), adults | 4% to 5% | 1% | Zepbound label |
| Tirzepatide, SURMOUNT-1 trial | About 5% | About 1% | Jastreboff et al., NEJM 2022 |
| Ozempic (semaglutide), type 2 diabetes | Not listed as a common reaction | Not applicable | Ozempic label |
Two patterns stand out. First, reported rates are higher in the weight-management trials, where weight loss is larger, and the Wegovy label shows hair loss was more frequent at the highest dose studied. Second, women appear more affected. In the Zepbound trials, 7.1% of women reported hair loss compared with 0.5% of men (placebo: 1.3% of women and 0% of men) (Zepbound prescribing information).
A 2025 insurance-claims study of people without diabetes compared new users of semaglutide with users of another weight-loss medicine. Among women, semaglutide users had roughly twice the risk of a hair loss diagnosis (adjusted hazard ratio 2.08), while the result for all patients combined was not statistically significant (Etminan et al., medRxiv preprint, 2025). It is a preprint, so treat it as early evidence rather than a settled answer.
Why GLP-1 medicines can trigger shedding
Scalp hairs cycle through a long growing phase (anagen) and a short resting phase (telogen), after which the old hair falls out and a new one begins. A significant stress on the body can push many follicles into the resting phase at the same time, and a few months later those hairs shed together. The American Academy of Dermatology lists losing 20 pounds or more among the common triggers, alongside childbirth, high fever, surgery and illness (AAD).
Several features of GLP-1 treatment can add to that stress:
- Speed and size of weight loss. Both the Wegovy and Zepbound labels state that hair loss reactions were associated with weight reduction.
- Eating much less. A reduced appetite can mean lower intake of protein, iron and zinc. After bariatric surgery, another cause of rapid weight loss, low iron, zinc and protein have all been linked to hair loss (Smolarczyk et al., Medicina, 2024).
- Other contributors. Thyroid problems, low iron stores, recent illness, other new medicines and hormonal changes can cause or worsen shedding, so they are worth checking rather than assuming the GLP-1 is the only factor.
Weight-loss surgery offers a useful comparison. A 2024 review reported a pooled hair loss incidence of 57% after bariatric surgery, typically starting around three months after the operation, and described it as usually self-limiting (Smolarczyk et al., 2024). Medication-driven weight loss is usually more gradual, which may help explain why trial rates are much lower.
When it starts and how long it lasts
Telogen effluvium shows up a few months after the trigger, not right away. The AAD notes that normal daily shedding is about 50 to 100 hairs, and that once the body readjusts, hair usually regains its normal fullness within about six to nine months. Shedding can last longer if the stressor continues (AAD). With a GLP-1 medicine, the stressor may last as long as rapid weight loss does, so shedding often settles once weight stabilizes.
Telogen effluvium thins hair across the whole scalp but does not destroy follicles, which is why recovery is expected. Regrowth is gradual, though: new hairs start short, so it can take months before the difference is visible in a ponytail or part.
Shedding or pattern hair loss? How to tell the difference
Here is the angle most articles skip: weight-loss shedding can happen at the same time as, or make you notice, androgenetic alopecia (male or female pattern hair loss) that was already developing. The two behave differently.
| Feature | Telogen effluvium | Pattern hair loss |
|---|---|---|
| Onset | Fairly sudden, a few months after a trigger | Gradual, over years |
| Where | All over the scalp; more hair in the shower and brush | Temples, hairline and crown in men; widening part in women |
| The hairs | Many full-length hairs shed | Hairs become finer and shorter over time |
| Outlook | Usually recovers once the trigger settles | Tends to progress without treatment |
If your part is widening, your hairline is moving back, or your crown keeps thinning after the shedding has slowed, pattern hair loss may be involved. Our Norwood scale guide shows the typical male stages, and a dermatologist can confirm the diagnosis, often with a close-up scalp examination.
What may help
- Do not stop or change your medicine on your own. Talk to your prescriber first. Shedding from telogen effluvium is usually temporary, and whether to continue treatment is a decision for you and your doctor.
- Ask about the pace of weight loss. Your prescriber can review whether your current plan is right for you.
- Prioritize protein and balanced meals. When appetite is low, small meals that include protein can make nutritional needs easier to meet. A registered dietitian can help.
- Ask about blood tests if shedding is heavy, such as iron stores, thyroid function, zinc and vitamin B12, rather than guessing with high-dose supplements.
- Be gentle with your hair. Avoid tight styles, harsh chemical treatments and excessive heat while hair is shedding.
- Treat pattern hair loss separately. If a dermatologist finds androgenetic alopecia, there are evidence-based options, several of which require a prescription. Talk to a doctor or dermatologist about whether any suit you.
When to see a dermatologist
- Heavy shedding that continues for more than about six months, or after your weight has stabilized.
- Round or patchy areas of complete hair loss, which can point to alopecia areata rather than shedding.
- Scalp pain, burning, redness, scaling or itching.
- Loss of eyebrows, eyelashes or body hair.
- Thinning concentrated at the hairline, crown or part.
Our guide on when to see a dermatologist for hair loss explains what to expect at the appointment and which questions to ask.
Planning a hair transplant while on a GLP-1?
Telogen effluvium is not usually treated with surgery, because the shed hair is expected to return. If you have pattern hair loss and are considering a transplant, many surgeons prefer to wait until your weight and any shedding have settled so they can assess your true hair density and donor supply. Tell your surgical team about any GLP-1 medicine you take, since they may give you specific instructions before sedation and healing. Our guides on hair transplant cost and hair transplant recovery explain what to expect.
Frequently asked questions
Does Ozempic cause hair loss?
Hair loss is reported with semaglutide and tirzepatide, but in trials it affected a minority of people. In Wegovy weight-management trials, 3% of adults reported hair loss versus 1% on placebo. The labels link it to weight reduction, and most experts think rapid weight loss triggers a temporary shedding condition called telogen effluvium.
Is hair loss from Ozempic permanent?
Shedding from telogen effluvium is usually temporary. The American Academy of Dermatology says hair usually regains its normal fullness within about six to nine months once the body readjusts. If thinning continues, a dermatologist can check for pattern hair loss or other causes.
When does hair loss start on GLP-1 medicines?
Telogen effluvium typically appears a few months after the trigger, so shedding is often noticed two to four months after significant weight loss begins rather than in the first weeks.
Do Mounjaro and Zepbound cause hair loss?
Tirzepatide, the ingredient in Mounjaro and Zepbound, has also been linked to hair loss. In Zepbound trials, 4% to 5% of people reported hair loss versus 1% on placebo, and it was more common in women (7.1%) than men (0.5%).
Should I stop my GLP-1 medicine if my hair is shedding?
Do not stop or change the medicine on your own. Talk to your prescriber, who can review the pace of weight loss, your nutrition and whether blood tests such as iron stores or thyroid function are needed.